AVEO Pharmaceuticals (AVEO)
Q2 2012 Earnings Call
August 02, 2012 10:00 am ET
Tuan Ha-Ngoc - Chief Executive Officer, President and Director
William J. Slichenmyer - Chief Medical Officer
David B. Johnston - Chief Financial Officer and Principal Accounting Officer
Michael P. Bailey - Chief Commercial Officer
John S. Sonnier - William Blair & Company L.L.C., Research Division
Adnan S. Butt - RBC Capital Markets, LLC, Research Division
Anupam Rama - JP Morgan Chase & Co, Research Division
Marshall Urist - Morgan Stanley, Research Division
Thomas Wei - Jefferies & Company, Inc., Research Division
Salveen J. Richter - Canaccord Genuity, Research Division
Howard Liang - Leerink Swann LLC, Research Division
Good day, ladies and gentlemen, and welcome to the AVEO Oncology Second Quarter 2012 Financial Results Conference Call. My name is Derek, and I'll be your operator for today. [Operator Instructions] As a reminder, this conference is the recorded for replay purposes. I would now like to turn the conference over to Ms. Monique Allaire, Director of Investor Relations. Please proceed.
Thank you, Derek, and good morning, everyone. Today, we'll be talking about our second quarter 2012 financial results and key recent developments and achievements. With me are Tuan Ha-Ngoc, our President and Chief Executive Officer; Bill Slichenmyer, our Chief Medical Officer; and David Johnston, our Chief Financial Officer. In addition, joining us for the Q&A session will be Michael Bailey, our Chief Commercial Officer; and Elan Ezickson, our Executive Vice President and Chief Operating Officer.
The press release issued earlier today detailing our results is available on our website at aveooncology.com.